Clinical trials
Completed Phase 1/2 Lung Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
120 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 4 |
| 2002 | 4 |
| 2003 | 10 |
| 2004 | 2 |
| 2005 | 5 |
| 2006 | 5 |
| 2007 | 3 |
| 2008 | 6 |
| 2009 | 9 |
| 2010 | 6 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 8 |
| 2015 | 11 |
| 2016 | 4 |
| 2017 | 9 |
| 2018 | 5 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 120 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fuda Cancer Hospital, Guangzhou | 9 |
| Memorial Sloan Kettering Cancer Center | 8 |
| M.D. Anderson Cancer Center | 6 |
| Incyte Corporation | 4 |
| Radiation Therapy Oncology Group | 4 |
| University of California, Davis | 4 |
| University of Alabama at Birmingham | 3 |
| H. Lee Moffitt Cancer Center and Research Institute | 2 |
| Massachusetts General Hospital | 2 |
| NCIC Clinical Trials Group | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 120 |
| Carcinoma, Non-Small-Cell Lung | 59 |
| Neoplasms | 15 |
| Breast Neoplasms | 14 |
| Colorectal Neoplasms | 11 |
| Ovarian Neoplasms | 11 |
| Head and Neck Neoplasms | 10 |
| Melanoma | 10 |
| Pancreatic Neoplasms | 9 |
| Colonic Neoplasms | 8 |
Trials
Showing 1 to 25 of 120. Each trial links to its page on Pharma Observatory.
20 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.